Daratumumab and Hyaluronidase/Dexamethasone/Lenalidomide Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of daratumumab and hyaluronidase, dexamethasone and lenalidomide that is used for the treatment of plasma cell myeloma.

**Synonyms:** - DRD (Daratumumab SC) - Dara (Daratumumab Subcutaneous)-RD Regimen - Dara-RD (SC Daratumumab) - Dara-Rd (SC daratumumab) - Daratumumab SC-Rd Regimen - Daratumumab Subcutaneous-Lenalidomide-Dexamethasone Regimen - Daratumumab and Hyaluronidase-Dexamethasone-Lenalidomide Regimen - Daratumumab and Hyaluronidase-Rd Regimen - Daratumumab and Hyaluronidase-fihj/Lenalidomide/Dexamethasone Regimen - Daratumumab and Hyaluronidase/Lenalidomide/Dexamethasone Regimen - Daratumumab-Hyaluronidase/Lenalidomide/Dexamethasone - Daratumumab/Hyaluronidase-Lenalidomide-Dexamethasone - Daratumumab/Hyaluronidase-Rd Regimen - Daratumumab/Recombinant Human Hyaluronidase/Lenalidomide/Dexamethasone Regimen - Darzalex Faspro-Dexamethasone-Lenalidomide - Darzalex Faspro/Lenalidomide/Dexamethasone Regimen - Darzalex Faspro/Revlimid/Decadron Regimen - Lenalidomide-Dexamethasone Plus Daratumumab and Hyaluronidase - Lenalidomide-Dexamethasone Plus Daratumumab and Hyaluronidase-fihj - Lenalidomide/Daratumumab and Hyaluronidase-fihj/Dexamethasone Regimen - Lenalidomide/Daratumumab and Hyaluronidase/Dexamethasone - Lenalidomide/Dexamethasone Plus Daratumumab and Hyaluronidase Regimen - Lenalidomide/Dexamethasone Plus Darzalex Faspro - Revlimid-Decadron Plus Darzalex Faspro Regimen